| 1 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services.
|
| 2 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 3 |
Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma. Cancer. 2015 Aug 1;121(15):2612-7.
|
| 4 |
Clinical pipeline report, company report or official report of Galena Biopharma.
|
| 5 |
ClinicalTrials.gov (NCT01244438) Study of FP-1039 in Subjects With Endometrial Cancers. U.S. National Institutes of Health.
|
| 6 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7936).
|
| 7 |
ClinicalTrials.gov (NCT02064725) Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA. U.S. National Institutes of Health.
|
| 8 |
Clinical pipeline report, company report or official report of Galena biopharma.
|
| 9 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035004)
|
| 10 |
ClinicalTrials.gov (NCT02580747) Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso
|
| 11 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028447)
|
| 12 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003252)
|
| 13 |
Expression of a retinol dehydrogenase (hRoDH-4), a member of the retinol/steroid dehydrogenase family implicated in retinoic acid biosynthesis, in normal and neoplastic endometria.Am J Obstet Gynecol. 2002 Apr;186(4):675-83. doi: 10.1067/mob.2002.122127.
|
| 14 |
Circulating adipokines and risk of obesity related cancers: A systematic review and meta-analysis.Obes Res Clin Pract. 2019 Jul-Aug;13(4):329-339. doi: 10.1016/j.orcp.2019.03.006. Epub 2019 Apr 16.
|
| 15 |
High AGR2 protein is a feature of low grade endometrial cancer cells.Oncotarget. 2018 Jul 31;9(59):31459-31472. doi: 10.18632/oncotarget.25838. eCollection 2018 Jul 31.
|
| 16 |
Silencing of angiotensin receptor 1 interferes with angiotensin II oncogenic activity in endometrial cancer.J Cell Biochem. 2018 Nov;119(11):9110-9121. doi: 10.1002/jcb.27174. Epub 2018 Aug 13.
|
| 17 |
AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer.Mol Cell Endocrinol. 2006 Mar 27;248(1-2):126-35. doi: 10.1016/j.mce.2005.10.009. Epub 2005 Dec 9.
|
| 18 |
Delayed endometrial decidualisation in polycystic ovary syndrome; the role of AR-MAGEA11.J Mol Med (Berl). 2019 Sep;97(9):1315-1327. doi: 10.1007/s00109-019-01809-6. Epub 2019 Jun 29.
|
| 19 |
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors.Nat Med. 2017 Sep;23(9):1046-1054. doi: 10.1038/nm.4372. Epub 2017 Aug 14.
|
| 20 |
Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma.EBioMedicine. 2019 Feb;40:276-289. doi: 10.1016/j.ebiom.2018.12.044. Epub 2018 Dec 26.
|
| 21 |
CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk.Twin Res Hum Genet. 2011 Aug;14(4):328-32. doi: 10.1375/twin.14.4.328.
|
| 22 |
Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer.Acta Radiol. 2018 Aug;59(8):1010-1017. doi: 10.1177/0284185117740932. Epub 2017 Nov 14.
|
| 23 |
Genetic variants in the microRNA machinery gene (Dicer) have a prognostic value in the management of endometrial cancer.J Cancer Res Ther. 2018 Oct-Dec;14(6):1279-1284. doi: 10.4103/0973-1482.187291.
|
| 24 |
RG108 induces the apoptosis of endometrial cancer Ishikawa cell lines by inhibiting the expression of DNMT3B and demethylation of HMLH1.Eur Rev Med Pharmacol Sci. 2017 Nov;21(22):5056-5064. doi: 10.26355/eurrev_201711_13818.
|
| 25 |
Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway.Gynecol Oncol. 2019 Jul;154(1):207-217. doi: 10.1016/j.ygyno.2019.04.005. Epub 2019 Apr 9.
|
| 26 |
The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERR through AKT and ERK1/2.Eur J Cancer Prev. 2014 Sep;23(5):418-24. doi: 10.1097/CEJ.0000000000000052.
|
| 27 |
Upregulation of miR-183-5p is responsible for the promotion of apoptosis and inhibition of the epithelial-mesenchymal transition, proliferation, invasion and migration of human endometrial cancer cells by downregulating Ezrin.Int J Mol Med. 2018 Nov;42(5):2469-2480. doi: 10.3892/ijmm.2018.3853. Epub 2018 Sep 4.
|
| 28 |
Autocrine motility factor promotes endometrial cancer progression by targeting GPER-1.Cell Commun Signal. 2019 Mar 5;17(1):22. doi: 10.1186/s12964-019-0336-4.
|
| 29 |
Hepatoma-Derived Growth Factor and DDX5 Promote Carcinogenesis and Progression of Endometrial Cancer by Activating -Catenin.Front Oncol. 2019 Apr 11;9:211. doi: 10.3389/fonc.2019.00211. eCollection 2019.
|
| 30 |
Roles of SIRT1/FoxO1/SREBP-1 in the development of progestin resistance in endometrial cancer.Arch Gynecol Obstet. 2018 Nov;298(5):961-969. doi: 10.1007/s00404-018-4893-3. Epub 2018 Sep 11.
|
| 31 |
Local estrogen metabolism (intracrinology) in endometrial cancer: A systematic review.Mol Cell Endocrinol. 2019 Jun 1;489:45-65. doi: 10.1016/j.mce.2018.10.004. Epub 2018 Oct 13.
|
| 32 |
Expression and functional significance of HtrA1 loss in endometrial cancer.Clin Cancer Res. 2011 Feb 1;17(3):427-36. doi: 10.1158/1078-0432.CCR-09-3069. Epub 2010 Nov 23.
|
| 33 |
Safety Studies in Tumor and Non-Tumor-Bearing Mice in Support of Clinical Trials Using Oncolytic VSV-IFN-NIS.Hum Gene Ther Clin Dev. 2016 Sep;27(3):111-22. doi: 10.1089/humc.2016.061.
|
| 34 |
IGFBP-rP1 acts as a potential tumor suppressor via the suppression of ERK signaling pathway in endometrial cancer cells.Mol Med Rep. 2017 Aug;16(2):1445-1450. doi: 10.3892/mmr.2017.6713. Epub 2017 Jun 7.
|
| 35 |
Colonystimulating factor 1 receptor inhibition blocks macrophage infiltration and endometrial cancer cell proliferation.Mol Med Rep. 2019 Apr;19(4):3139-3147. doi: 10.3892/mmr.2019.9963. Epub 2019 Feb 18.
|
| 36 |
Blockage of intermediate-conductance-Ca(2+) -activated K(+) channels inhibits progression of human endometrial cancer.Oncogene. 2007 Aug 2;26(35):5107-14. doi: 10.1038/sj.onc.1210308. Epub 2007 Feb 19.
|
| 37 |
TGF- activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth.Cell Cycle. 2016;15(7):931-47. doi: 10.1080/15384101.2016.1150393.
|
| 38 |
Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.Int J Gynecol Cancer. 2009 Nov;19(8):1377-83. doi: 10.1111/IGC.0b013e3181a83e1a.
|
| 39 |
Altered expression of lysophosphatidic acid receptors, in association with the synthesis of estrogens and androgens in type 1 endometrial cancer biology.Gynecol Endocrinol. 2018 May;34(5):422-427. doi: 10.1080/09513590.2017.1409707. Epub 2017 Nov 28.
|
| 40 |
The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.Int J Gynecol Cancer. 2013 Jan;23(1):52-9. doi: 10.1097/IGC.0b013e31827912b8.
|
| 41 |
Impact of MDM2, TP53 and P14ARF Polymorphisms on Endometrial Cancer Risk and Onset.In Vivo. 2019 May-Jun;33(3):917-924. doi: 10.21873/invivo.11559.
|
| 42 |
Overexpression of the matrix metalloproteinase 11 gene is a potential biomarker for type 1 endometrial cancer.Oncol Lett. 2018 Jul;16(1):1073-1078. doi: 10.3892/ol.2018.8714. Epub 2018 May 16.
|
| 43 |
MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment.Oncotarget. 2016 Jan 26;7(4):4559-69. doi: 10.18632/oncotarget.6610.
|
| 44 |
Comparison of serum human epididymis protein 4 and CA125 on endometrial cancer detection: A meta-analysis.Clin Chim Acta. 2019 Jan;488:215-220. doi: 10.1016/j.cca.2018.11.011. Epub 2018 Nov 7.
|
| 45 |
Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.Int J Cancer. 2016 Oct 1;139(7):1557-63. doi: 10.1002/ijc.30197. Epub 2016 Jun 2.
|
| 46 |
Association analysis between 8-oxoguanine DNA glycosylase genetic variants and endometrial cancer susceptibility in Chinese Han population.J Pharm Pharmacol. 2015 Apr;67(4):559-64. doi: 10.1111/jphp.12348. Epub 2014 Dec 10.
|
| 47 |
Cross-talk between p21-activated kinase 4 and ER signaling triggers endometrial cancer cell proliferation.Oncotarget. 2017 Jul 12;8(40):68083-68094. doi: 10.18632/oncotarget.19188. eCollection 2017 Sep 15.
|
| 48 |
Inhibition of protein methylesterase 1 decreased cancerous phenotypes in endometrial adenocarcinoma cell lines and xenograft tumor models.Tumour Biol. 2016 Sep;37(9):11835-11842. doi: 10.1007/s13277-016-5036-8. Epub 2016 Apr 5.
|
| 49 |
Bu Shen Yang Xue Prescription Has Treating Effect on Endometrial Cancer through FSH/PI3K/AKT/Gankyrin/HIF-/cyclinD 1 Pathway in Ishikawa Cells.Evid Based Complement Alternat Med. 2018 Oct 9;2018:8412984. doi: 10.1155/2018/8412984. eCollection 2018.
|
| 50 |
Prostaglandin E2 triggers cytochrome P450 17 hydroxylase overexpression via signal transducer and activator of transcription 3 phosphorylation and promotes invasion in endometrial cancer.Oncol Lett. 2018 Oct;16(4):4577-4585. doi: 10.3892/ol.2018.9165. Epub 2018 Jul 18.
|
| 51 |
Isomorph expression of BAG-1 gene, ER and PR in endometrial cancer.Anticancer Res. 2010 Oct;30(10):4103-8.
|
| 52 |
Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status.Oncol Rep. 2004 Feb;11(2):427-33.
|
| 53 |
Expression of organic cation transporter SLC22A16 in human endometria.Int J Gynecol Pathol. 2007 Jan;26(1):53-60. doi: 10.1097/01.pgp.0000225845.67245.b3.
|
| 54 |
Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform.Oncotarget. 2015 Sep 8;6(26):22553-63. doi: 10.18632/oncotarget.4155.
|
| 55 |
Nucleotide excision repair genotype and the incidence of endometrial cancer: effect of other risk factors on the association.Gynecol Oncol. 2006 Dec;103(3):891-6. doi: 10.1016/j.ygyno.2006.05.020. Epub 2006 Jun 23.
|
| 56 |
ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer.Oncotarget. 2018 Mar 30;9(24):16648-16664. doi: 10.18632/oncotarget.24625. eCollection 2018 Mar 30.
|
| 57 |
Downregulation of Proline Hydroxylase 2 and Upregulation of Hypoxia-Inducible Factor 1 are Associated with Endometrial Cancer Aggressiveness.Cancer Manag Res. 2019 Nov 22;11:9907-9912. doi: 10.2147/CMAR.S223421. eCollection 2019.
|
| 58 |
Expression Profile of VEGF-C, VEGF-D, and VEGFR-3 in Different Grades of Endometrial Cancer.Curr Pharm Biotechnol. 2019;20(12):1004-1010. doi: 10.2174/1389201020666190718164431.
|
| 59 |
Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients.Cancer Med. 2019 Aug;8(10):4678-4687. doi: 10.1002/cam4.2378. Epub 2019 Jul 5.
|
| 60 |
Regulation of matriptase and HAI-1 system, a novel therapeutic target in human endometrial cancer cells.Oncotarget. 2018 Jan 3;9(16):12682-12694. doi: 10.18632/oncotarget.23913. eCollection 2018 Feb 27.
|
| 61 |
NEDD4 ubiquitin ligase is a putative oncogene in endometrial cancer that activates IGF-1R/PI3K/Akt signaling.Gynecol Oncol. 2015 Oct;139(1):127-33. doi: 10.1016/j.ygyno.2015.07.098. Epub 2015 Jul 17.
|
| 62 |
High throughput silencing identifies novel genes in endometrioid endometrial cancer.Taiwan J Obstet Gynecol. 2018 Apr;57(2):217-226. doi: 10.1016/j.tjog.2018.02.009.
|
| 63 |
Altered expression of genes involved in progesterone biosynthesis, metabolism and action in endometrial cancer.Chem Biol Interact. 2013 Feb 25;202(1-3):210-7. doi: 10.1016/j.cbi.2012.11.012. Epub 2012 Nov 27.
|
| 64 |
Tumor-suppressive effects of CDK8 in endometrial cancer cells.Cell Cycle. 2013 Mar 15;12(6):987-99. doi: 10.4161/cc.24003. Epub 2013 Mar 1.
|
| 65 |
Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition.Proc Natl Acad Sci U S A. 2019 Dec 17;116(51):25880-25890. doi: 10.1073/pnas.1911310116. Epub 2019 Nov 26.
|
| 66 |
Use of Porphysomes to detect primary tumour, lymph node metastases, intra-abdominal metastases and as a tool for image-guided lymphadenectomy: proof of concept in endometrial cancer.Theranostics. 2019 Apr 13;9(9):2727-2738. doi: 10.7150/thno.31225. eCollection 2019.
|
| 67 |
Folate receptor- targeted near-infrared fluorescence imaging in high-risk endometrial cancer patients: a tissue microarray and clinical feasibility study.Oncotarget. 2017 Dec 11;9(1):791-801. doi: 10.18632/oncotarget.23155. eCollection 2018 Jan 2.
|
| 68 |
The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer.Int J Oncol. 2015 Jul;47(1):325-34. doi: 10.3892/ijo.2015.2986. Epub 2015 May 5.
|
| 69 |
PGF2-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer.BMC Cancer. 2010 Sep 14;10:488. doi: 10.1186/1471-2407-10-488.
|
| 70 |
Lysophosphatidic acid acyltransferase-beta is a prognostic marker and therapeutic target in gynecologic malignancies.Cancer Res. 2005 Oct 15;65(20):9415-25. doi: 10.1158/0008-5472.CAN-05-0516.
|
| 71 |
Transcriptome analysis reveals that Mllerian inhibiting substance regulates signaling pathways that contribute to endometrial carcinogenesis.Int J Oncol. 2015 May;46(5):2039-46. doi: 10.3892/ijo.2015.2920. Epub 2015 Mar 6.
|
| 72 |
Beta-arrestin 2 modulates resveratrol-induced apoptosis and regulation of Akt/GSK3? pathways. Biochim Biophys Acta. 2010 Sep;1800(9):912-8. doi: 10.1016/j.bbagen.2010.04.015. Epub 2010 May 7.
|
| 73 |
-arrestin-2 up-regulates toll-like receptor 2 signaling and inhibits apoptosis in human endometrial cancer heterotransplants in nude mice.BMC Cancer. 2019 Nov 1;19(1):1035. doi: 10.1186/s12885-019-6254-4.
|
| 74 |
ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma.Oncotarget. 2015 Sep 29;6(29):28440-52. doi: 10.18632/oncotarget.4955.
|
| 75 |
Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells.Cancers (Basel). 2019 Dec 1;11(12):1913. doi: 10.3390/cancers11121913.
|
| 76 |
Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.Int J Cancer. 2013 Jan 15;132(2):472-84. doi: 10.1002/ijc.27679. Epub 2012 Jul 9.
|
| 77 |
Identification and allelic frequencies of novel single-nucleotide polymorphisms in the DUSP1 and BTG1 genes.J Hum Genet. 2001;46(3):155-7. doi: 10.1007/s100380170105.
|
| 78 |
Overexpression of HABP1 correlated with clinicopathological characteristics and unfavorable prognosis in endometrial cancer.Tumour Biol. 2015 Feb;36(2):1299-306. doi: 10.1007/s13277-014-2761-8. Epub 2014 Oct 30.
|
| 79 |
Progesterone induces cell apoptosis via the CACNA2D3/Ca2+/p38 MAPK pathway in endometrial cancer.Oncol Rep. 2020 Jan;43(1):121-132. doi: 10.3892/or.2019.7396. Epub 2019 Oct 31.
|
| 80 |
Analysis of candidate target genes for mononucleotide repeat mutation in microsatellite instability-high (MSI-H) endometrial cancer.Int J Oncol. 2009 Nov;35(5):977-82. doi: 10.3892/ijo_00000411.
|
| 81 |
Polymorphisms and haplotypes in the caspase-3, caspase-7, and caspase-8 genes and risk for endometrial cancer: a population-based, case-control study in a Chinese population.Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2114-22. doi: 10.1158/1055-9965.EPI-09-0152. Epub 2009 Jun 16.
|
| 82 |
MicroRNA?95 inhibits epithelialmesenchymal transition by targeting G proteincoupled estrogen receptor 1 in endometrial carcinoma.Mol Med Rep. 2019 Nov;20(5):4023-4032. doi: 10.3892/mmr.2019.10652. Epub 2019 Sep 6.
|
| 83 |
Identification of prognosis markers for endometrial cancer by integrated analysis of DNA methylation and RNA-Seq data.Sci Rep. 2019 Jul 9;9(1):9924. doi: 10.1038/s41598-019-46195-8.
|
| 84 |
Deep and Durable Response With Combination CTLA-4 and PD-1 Blockade in Mismatch Repair (MMR)-proficient Endometrial Cancer.J Immunother. 2019 Feb-Mar;42(2):51-54. doi: 10.1097/CJI.0000000000000244.
|
| 85 |
Identification of Potential Crucial Genes Associated With the Pathogenesis and Prognosis of Endometrial Cancer.Front Genet. 2019 Apr 26;10:373. doi: 10.3389/fgene.2019.00373. eCollection 2019.
|
| 86 |
MiR-449a functions as a tumor suppressor in endometrial cancer by targeting CDC25A.Oncol Rep. 2014 Sep;32(3):1193-9. doi: 10.3892/or.2014.3303. Epub 2014 Jul 3.
|
| 87 |
Alteration of G2 cell cycle regulators occurs during carcinogenesis of the endometrium.Oncology. 2003;65(2):159-66. doi: 10.1159/000072342.
|
| 88 |
hLH/hCG-receptor expression correlates with in vitro invasiveness in human primary endometrial cancer.Gynecol Oncol. 2008 Dec;111(3):496-501. doi: 10.1016/j.ygyno.2008.08.018. Epub 2008 Oct 1.
|
| 89 |
Structure, expression and mutational analysis of the hBRAG gene on 10q in the frequently deleted region in human endometrial cancer.Oncol Rep. 2000 Nov-Dec;7(6):1339-42. doi: 10.3892/or.7.6.1339.
|
| 90 |
Catechol-O-methyltransferase and cytochrome P-450 1B1 polymorphisms and endometrial cancer risk: a meta-analysis.Int J Gynecol Cancer. 2013 Mar;23(3):422-30. doi: 10.1097/IGC.0b013e3182849e0d.
|
| 91 |
Urocortin suppresses endometrial cancer cell migration via CRFR2 and its system components are differentially modulated by estrogen.Cancer Med. 2017 Feb;6(2):408-415. doi: 10.1002/cam4.967. Epub 2017 Jan 21.
|
| 92 |
Chondroitin sulfate proteoglycan protein is stimulated by interleukin11 and promotes endometrial epithelial cancer cell proliferation and migration.Int J Oncol. 2017 Mar;50(3):798-804. doi: 10.3892/ijo.2017.3848. Epub 2017 Jan 13.
|
| 93 |
Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.Oncotarget. 2014 Feb 28;5(4):1052-61. doi: 10.18632/oncotarget.1697.
|
| 94 |
Immunohistochemical Nuclear Expression of -Catenin as a Surrogate of CTNNB1 Exon 3 Mutation in Endometrial Cancer.Am J Clin Pathol. 2019 Apr 2;151(5):529-538. doi: 10.1093/ajcp/aqy178.
|
| 95 |
Expression of cysteine protease cathepsin L is increased in endometrial cancer and correlates with expression of growth regulatory genes.Cancer Invest. 2012 Jun;30(5):398-403. doi: 10.3109/07357907.2012.672608. Epub 2012 Mar 27.
|
| 96 |
Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.Cytokine. 2013 Nov;64(2):509-15. doi: 10.1016/j.cyto.2013.07.024. Epub 2013 Aug 25.
|
| 97 |
Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use.Carcinogenesis. 2007 Oct;28(10):2139-42. doi: 10.1093/carcin/bgm087. Epub 2007 Apr 13.
|
| 98 |
Argininosuccinate Synthase 1-Deficiency Enhances the Cell Sensitivity to Arginine through Decreased DEPTOR Expression in Endometrial Cancer.Sci Rep. 2017 Mar 30;7:45504. doi: 10.1038/srep45504.
|
| 99 |
Diacylglycerol kinase mediates 17--estradiol-induced proliferation, motility, and anchorage-independent growth of Hec-1A endometrial cancer cell line through the G protein-coupled estrogen receptor GPR30.Cell Signal. 2011 Dec;23(12):1988-96. doi: 10.1016/j.cellsig.2011.07.009. Epub 2011 Jul 22.
|
| 100 |
A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer.Clin Proteomics. 2018 Dec 1;15:38. doi: 10.1186/s12014-018-9216-y. eCollection 2018.
|
| 101 |
Significance of calreticulin as a prognostic factor in endometrial cancer.Oncol Lett. 2018 Jun;15(6):8999-9008. doi: 10.3892/ol.2018.8495. Epub 2018 Apr 13.
|
| 102 |
CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis.BMC Cancer. 2019 Apr 29;19(1):401. doi: 10.1186/s12885-019-5556-x.
|
| 103 |
Dual targeting of estrogen receptor and estrogen-related receptor : a novel endocrine therapy for endometrial cancer.Onco Targets Ther. 2019 Aug 20;12:6757-6767. doi: 10.2147/OTT.S216146. eCollection 2019.
|
| 104 |
The agonist activity of tamoxifen is inhibited by the short heterodimer partner orphan nuclear receptor in human endometrial cancer cells. Endocrinology. 2002 Mar;143(3):853-67.
|
| 105 |
Loss of polarity alters proliferation and differentiation in low-grade endometrial cancers by disrupting Notch signaling.PLoS One. 2017 Dec 5;12(12):e0189081. doi: 10.1371/journal.pone.0189081. eCollection 2017.
|
| 106 |
Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.Cancer Res. 2007 Mar 1;67(5):1927-34. doi: 10.1158/0008-5472.CAN-06-2687.
|
| 107 |
Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.Biomed Pharmacother. 2019 Jul;115:108939. doi: 10.1016/j.biopha.2019.108939. Epub 2019 May 9.
|
| 108 |
Comparative Study of the Effects of Ferrochelatase-siRNA Transfection Mediated by Ultrasound Microbubbles and Polyethyleneimine in Combination with Low-dose ALA to Enhance PpIX Accumulation in Human Endometrial Cancer Xenograft Nude Mice Models.Photochem Photobiol. 2019 Jul;95(4):1045-1051. doi: 10.1111/php.13076. Epub 2019 Feb 11.
|
| 109 |
Expressions of the fibroblast growth factor family (FGF-1, -2 and -4) mRNA in endometrial cancers.Tumour Biol. 1996;17(4):226-33. doi: 10.1159/000217984.
|
| 110 |
FTO expression is associated with the occurrence of gastric cancer and prognosis.Oncol Rep. 2017 Oct;38(4):2285-2292. doi: 10.3892/or.2017.5904. Epub 2017 Aug 14.
|
| 111 |
GALR1 methylation in vaginal swabs is highly accurate in identifying women with endometrial cancer.Int J Gynecol Cancer. 2013 Jul;23(6):1050-5. doi: 10.1097/IGC.0b013e3182959103.
|
| 112 |
Growth hormone-releasing hormone antagonist inhibits the invasiveness of human endometrial cancer cells by down-regulating twist and N-cadherin expression.Oncotarget. 2017 Jan 17;8(3):4410-4421. doi: 10.18632/oncotarget.13877.
|
| 113 |
(99m)Tc-LHRH in tumor receptor imaging.Oncol Lett. 2017 Jul;14(1):569-578. doi: 10.3892/ol.2017.6246. Epub 2017 May 24.
|
| 114 |
GnRH agonist inhibits human telomerase reverse transcriptase mRNA expression in endometrial cancer cells.Int J Mol Med. 2002 Nov;10(5):593-7.
|
| 115 |
Promoter hypermethylation of CIDEA, HAAO and RXFP3 associated with microsatellite instability in endometrial carcinomas.Gynecol Oncol. 2010 May;117(2):239-47. doi: 10.1016/j.ygyno.2010.02.006. Epub 2010 Mar 7.
|
| 116 |
Tumor-associated macrophage-derived CXCL8 could induce ER suppression via HOXB13 in endometrial cancer.Cancer Lett. 2016 Jun 28;376(1):127-36. doi: 10.1016/j.canlet.2016.03.036. Epub 2016 Mar 24.
|
| 117 |
Hepsin inhibits the cell growth of endometrial cancer.Int J Mol Med. 2008 Sep;22(3):389-97.
|
| 118 |
Blocking 17-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach.J Pathol. 2018 Feb;244(2):203-214. doi: 10.1002/path.5004. Epub 2018 Jan 3.
|
| 119 |
Polymorphisms in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial cancer risk.Gynecol Oncol. 2011 Apr;121(1):54-8. doi: 10.1016/j.ygyno.2010.11.014. Epub 2010 Dec 3.
|
| 120 |
Proteomic analysis in endometrial cancer and endometrial hyperplasia tissues by 2D-DIGE technique.J Gynecol Obstet Hum Reprod. 2020 Feb;49(2):101652. doi: 10.1016/j.jogoh.2019.101652. Epub 2019 Nov 26.
|
| 121 |
Discovery and validation of methylation markers for endometrial cancer.Int J Cancer. 2014 Oct 15;135(8):1860-8. doi: 10.1002/ijc.28843. Epub 2014 Mar 31.
|
| 122 |
Suppressed expression of insulin-like growth factor binding protein-1 mRNA in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors.Int J Cancer. 1994 Nov 1;59(3):307-12. doi: 10.1002/ijc.2910590303.
|
| 123 |
Targeting Interleukin-11 Receptor- Impairs Human Endometrial Cancer Cell Proliferation and Invasion In Vitro and Reduces Tumor Growth and Metastasis In Vivo.Mol Cancer Ther. 2016 Apr;15(4):720-30. doi: 10.1158/1535-7163.MCT-15-0677. Epub 2016 Feb 4.
|
| 124 |
KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.Oncotarget. 2015 Oct 13;6(31):31702-20. doi: 10.18632/oncotarget.5165.
|
| 125 |
Expression and clinical significance of KLK5-8 in endometrial cancer.Am J Transl Res. 2019 Jul 15;11(7):4180-4191. eCollection 2019.
|
| 126 |
Keratin 17 is a negative prognostic biomarker in high-grade endometrial carcinomas.Hum Pathol. 2019 Dec;94:40-50. doi: 10.1016/j.humpath.2019.09.005. Epub 2019 Oct 23.
|
| 127 |
Immune inhibitory receptor LILRB2 is critical for the endometrial cancer progression.Biochem Biophys Res Commun. 2018 Nov 17;506(1):243-250. doi: 10.1016/j.bbrc.2018.09.114. Epub 2018 Oct 19.
|
| 128 |
Novel breast cancer risk alleles and endometrial cancer risk.Int J Cancer. 2008 Dec 15;123(12):2961-4. doi: 10.1002/ijc.23862.
|
| 129 |
Multiple loci identified in a genome-wide association study of prostate cancer.Nat Genet. 2008 Mar;40(3):310-5. doi: 10.1038/ng.91. Epub 2008 Feb 10.
|
| 130 |
Deep Infiltrating Endometriosis and Endometrial Adenocarcinoma Express High Levels of Myostatin and Its Receptors Messenger RNAs.Reprod Sci. 2017 Dec;24(12):1577-1582. doi: 10.1177/1933719117698579. Epub 2017 Mar 27.
|
| 131 |
Ramelteon, a selective MT1/MT2 receptor agonist, suppresses the proliferation and invasiveness of endometrial cancer cells.Hum Cell. 2017 Jul;30(3):209-215. doi: 10.1007/s13577-017-0169-7. Epub 2017 Apr 5.
|
| 132 |
Cloning and functional expression of the hNPY Y5 receptor in human endometrial cancer (HEC-1B) cells.Can J Physiol Pharmacol. 2000 Feb;78(2):134-42.
|
| 133 |
Expression of NR1H3 in endometrial carcinoma and its effect on the proliferation of Ishikawa cells in vitro.Onco Targets Ther. 2019 Jan 18;12:685-697. doi: 10.2147/OTT.S180534. eCollection 2019.
|
| 134 |
Expression of NRP-1 and NRP-2 in Endometrial Cancer.Curr Pharm Biotechnol. 2019;20(3):254-260. doi: 10.2174/1389201020666190219121602.
|
| 135 |
Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome.Virchows Arch. 2017 Oct;471(4):521-530. doi: 10.1007/s00428-017-2215-y. Epub 2017 Aug 24.
|
| 136 |
Olfactomedin-4 regulation by estrogen in the human endometrium requires epidermal growth factor signaling. Am J Pathol. 2010 Nov;177(5):2495-508. doi: 10.2353/ajpath.2010.100026.
|
| 137 |
Expression and responsiveness of P2Y2 receptors in human endometrial cancer cell lines.J Clin Endocrinol Metab. 1999 Nov;84(11):4085-91. doi: 10.1210/jcem.84.11.6119.
|
| 138 |
Proprotein convertases in post-menopausal endometrial cancer: distinctive regulation and non-invasive diagnosis.Biochem Biophys Res Commun. 2012 Mar 23;419(4):809-14. doi: 10.1016/j.bbrc.2012.02.111. Epub 2012 Feb 27.
|
| 139 |
Over-expression of platelet-derived growth factor-D promotes tumor growth and invasion in endometrial cancer.Int J Mol Sci. 2014 Mar 18;15(3):4780-94. doi: 10.3390/ijms15034780.
|
| 140 |
Pepsinogen C expression, regulation and its relationship with cancer.Cancer Cell Int. 2017 May 23;17:57. doi: 10.1186/s12935-017-0426-6. eCollection 2017.
|
| 141 |
Negative regulation of AMPK1 by PIM2 promotes aerobic glycolysis and tumorigenesis in endometrial cancer.Oncogene. 2019 Sep;38(38):6537-6549. doi: 10.1038/s41388-019-0898-z. Epub 2019 Jul 29.
|
| 142 |
Individualised proteome profiling of human endometrial tumours improves detection of new prognostic markers.Br J Cancer. 2013 Aug 6;109(3):704-13. doi: 10.1038/bjc.2013.359. Epub 2013 Jul 9.
|
| 143 |
Laparoendoscopic Single-Site Sentinel Lymph Node Detection in Endometrial Cancer.J Minim Invasive Gynecol. 2018 Jul-Aug;25(5):776. doi: 10.1016/j.jmig.2017.10.035. Epub 2017 Nov 13.
|
| 144 |
Genomic Comparison of Endometrioid Endometrial Carcinoma and Its Precancerous Lesions in Chinese Patients by High-Depth Next Generation Sequencing.Front Oncol. 2019 Mar 4;9:123. doi: 10.3389/fonc.2019.00123. eCollection 2019.
|
| 145 |
Serum Prolactin Contributes to Enhancing Prolactin Receptor and pJAK2 in Type I Endometrial Cancer Cells in Young Women Without Insulin Resistance.Int J Gynecol Pathol. 2019 Jul;38(4):318-325. doi: 10.1097/PGP.0000000000000527.
|
| 146 |
Genetic variants in ER cofactor genes and endometrial cancer risk.PLoS One. 2012;7(8):e42445. doi: 10.1371/journal.pone.0042445. Epub 2012 Aug 2.
|
| 147 |
Gefitinib enhances sensitivity of endometrial cancer cells to progestin therapy via dual-specificity phosphatase 1.Oncotarget. 2017 Dec 15;8(70):115360-115369. doi: 10.18632/oncotarget.23264. eCollection 2017 Dec 29.
|
| 148 |
RICTOR expression in esophageal squamous cell carcinoma and its clinical significance.Med Oncol. 2017 Mar;34(3):32. doi: 10.1007/s12032-017-0894-5. Epub 2017 Jan 28.
|
| 149 |
ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.Gynecol Oncol. 2018 Mar;148(3):576-584. doi: 10.1016/j.ygyno.2018.01.025. Epub 2018 Feb 1.
|
| 150 |
Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the -Catenin Pathway in Endometrial Cancer.Int J Mol Sci. 2018 Aug 18;19(8):2438. doi: 10.3390/ijms19082438.
|
| 151 |
Expression of SCUBE2 gene declines in high grade endometrial cancer and associates with expression of steroid hormone receptors and tumor suppressor PTEN.Gynecol Endocrinol. 2013 Dec;29(12):1031-5. doi: 10.3109/09513590.2013.829441. Epub 2013 Sep 20.
|
| 152 |
Effects of sex steroid hormones on corticosteroid-binding globulin gene expression in human endometrial cancer cell line Ishikawa.Ann Clin Biochem. 1998 Sep;35 ( Pt 5):637-42. doi: 10.1177/000456329803500507.
|
| 153 |
Endometrial cancer surveillance adherence reduces utilization and subsequent costs.Gynecol Oncol. 2017 Sep;146(3):514-518. doi: 10.1016/j.ygyno.2017.06.024. Epub 2017 Jul 19.
|
| 154 |
A small compound spindlactone A sensitizes human endometrial cancer cells to TRAIL-induced apoptosis via the inhibition of NAD(P)H dehydrogenase quinone 1.Onco Targets Ther. 2018 Jun 21;11:3609-3617. doi: 10.2147/OTT.S165723. eCollection 2018.
|
| 155 |
CD47 Blockade Inhibits Tumor Progression through Promoting Phagocytosis of Tumor Cells by M2 Polarized Macrophages in Endometrial Cancer.J Immunol Res. 2018 Nov 7;2018:6156757. doi: 10.1155/2018/6156757. eCollection 2018.
|
| 156 |
Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium.Oncotarget. 2016 Jan 12;7(2):1144-54. doi: 10.18632/oncotarget.6691.
|
| 157 |
Negative Effect of Ellagic Acid on Cytosolic pH Regulation and Glycolytic Flux in Human Endometrial Cancer Cells.Cell Physiol Biochem. 2017;41(6):2374-2382. doi: 10.1159/000475655. Epub 2017 Apr 27.
|
| 158 |
SOX15 regulates proliferation and migration of endometrial cancer cells.Biosci Rep. 2017 Oct 17;37(5):BSR20171045. doi: 10.1042/BSR20171045. Print 2017 Oct 31.
|
| 159 |
Stanniocalcin-2 May Be a Potentially Valuable Prognostic Marker in Endometrial Cancer: a Preliminary Study.Pathol Oncol Res. 2019 Apr;25(2):751-757. doi: 10.1007/s12253-018-00576-y. Epub 2019 Jan 19.
|
| 160 |
Six-transmembrane epithelial antigen of the prostate 1 is associated with tumor invasion and migration in endometrial carcinomas.J Cell Biochem. 2019 Jul;120(7):11172-11189. doi: 10.1002/jcb.28393. Epub 2019 Feb 3.
|
| 161 |
Receptor Activator of Nuclear Factor Kappa B (RANK) and Clinicopathological Variables in Endometrial Cancer: A Study at Protein and Gene Level.Int J Mol Sci. 2018 Jun 22;19(7):1848. doi: 10.3390/ijms19071848.
|
| 162 |
TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway.Cancer Lett. 2010 Aug 1;294(1):91-100. doi: 10.1016/j.canlet.2010.01.027. Epub 2010 Feb 26.
|
| 163 |
Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.BMC Cancer. 2014 Nov 26;14:884. doi: 10.1186/1471-2407-14-884.
|
| 164 |
Telomere length and genetic analyses in population-based studies of endometrial cancer risk.Cancer. 2010 Sep 15;116(18):4275-82. doi: 10.1002/cncr.25328.
|
| 165 |
Topoisomerase II binding protein 1 c.*229C>T (rs115160714) gene polymorphism and endometrial cancer risk.Pathol Oncol Res. 2014 Jul;20(3):597-602. doi: 10.1007/s12253-013-9737-7. Epub 2013 Dec 18.
|
| 166 |
Role of the tripartite motif protein 27 in cancer development.J Natl Cancer Inst. 2012 Jun 20;104(12):941-52. doi: 10.1093/jnci/djs224. Epub 2012 May 3.
|
| 167 |
miR-214-3p inhibits epithelial-to-mesenchymal transition and metastasis of endometrial cancer cells by targeting TWIST1.Onco Targets Ther. 2019 Nov 18;12:9449-9458. doi: 10.2147/OTT.S181037. eCollection 2019.
|
| 168 |
Genetic variation in CYP17A1 and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California.Int J Cancer. 2010 Feb 1;126(3):790-5. doi: 10.1002/ijc.24792.
|
| 169 |
VISTA expressed in tumour cells regulates T cell function.Br J Cancer. 2019 Jan;120(1):115-127. doi: 10.1038/s41416-018-0313-5. Epub 2018 Nov 9.
|
| 170 |
Long Non-coding RNA CDKN2B Antisense RNA 1 Gene Contributes to Paclitaxel Resistance in Endometrial Carcinoma.Front Oncol. 2019 Jan 29;9:27. doi: 10.3389/fonc.2019.00027. eCollection 2019.
|
| 171 |
Metformin sensitizes endometrial cancer cells to progestin by targeting TET1 to downregulate glyoxalase I expression.Biomed Pharmacother. 2019 May;113:108712. doi: 10.1016/j.biopha.2019.108712. Epub 2019 Mar 6.
|
| 172 |
Quantitative RT-PCR Assay for Detecting Lymph Node Metastasis in Endometrial Cancer: A Preliminary Study.Oncology. 2019;96(4):179-182. doi: 10.1159/000493485. Epub 2018 Nov 14.
|
| 173 |
Identification of new fusion genes and their clinical significance in endometrial cancer.Chin Med J (Engl). 2019 Jun 5;132(11):1314-1321. doi: 10.1097/CM9.0000000000000203.
|
| 174 |
Knockout of glucose transporter GLUT6 has minimal effects on whole body metabolic physiology in mice.Am J Physiol Endocrinol Metab. 2018 Aug 1;315(2):E286-E293. doi: 10.1152/ajpendo.00082.2018. Epub 2018 Apr 17.
|
| 175 |
STAR and AKR1B10 are down-regulated in high-grade endometrial cancer.J Steroid Biochem Mol Biol. 2017 Jul;171:43-53. doi: 10.1016/j.jsbmb.2017.02.015. Epub 2017 Feb 21.
|
| 176 |
Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway.Oncotarget. 2016 Mar 1;7(9):10363-72. doi: 10.18632/oncotarget.7004.
|
| 177 |
Preoperative frailty is a risk factor for non-home discharge in patients undergoing surgery for endometrial cancer.J Geriatr Oncol. 2018 Sep;9(5):513-515. doi: 10.1016/j.jgo.2018.02.005. Epub 2018 Mar 9.
|
| 178 |
BAT-26 microsatellite instability does not correlate with the loss of hMLH1 and hMSH2 protein expression in sporadic endometrial cancers.Oncol Rep. 2003 Jul-Aug;10(4):1039-43.
|
| 179 |
Loss of heterozygosity of BRCA1, TP53 and TCRD markers analysed in sporadic endometrial cancer.Eur J Cancer. 1998 Oct;34(11):1770-6. doi: 10.1016/s0959-8049(98)00270-6.
|
| 180 |
GGC and StuI polymorphism on the androgen receptor gene in endometrial cancer patients.Biochem Biophys Res Commun. 2005 Apr 1;329(1):100-4. doi: 10.1016/j.bbrc.2005.01.104.
|
| 181 |
Abnormal expression of period 1 (PER1) in endometrial carcinoma.J Pathol. 2005 May;206(1):111-20. doi: 10.1002/path.1756.
|
| 182 |
Function of UDP-glucuronosyltransferase 2B17 (UGT2B17) is involved in endometrial cancer.Carcinogenesis. 2010 Sep;31(9):1620-6. doi: 10.1093/carcin/bgq124. Epub 2010 Jun 16.
|
| 183 |
Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk.Pharmacogenet Genomics. 2009 Mar;19(3):239-43. doi: 10.1097/FPC.0b013e328323f66c.
|
| 184 |
Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.Oncol Rep. 2012 May;27(5):1488-96. doi: 10.3892/or.2012.1670. Epub 2012 Feb 2.
|
| 185 |
Utility of diffusion-weighted imaging in association with pathologic upgrading in biopsy-proven grade I endometrial cancer.J Magn Reson Imaging. 2020 Jan;51(1):117-123. doi: 10.1002/jmri.26840. Epub 2019 Jun 17.
|
| 186 |
Mutual suppression between BHLHE40/BHLHE41 and the MIR301B-MIR130B cluster is involved in epithelial-to-mesenchymal transition of endometrial cancer cells.Oncotarget. 2019 Jul 23;10(45):4640-4654. doi: 10.18632/oncotarget.27061. eCollection 2019 Jul 23.
|
| 187 |
The relationships between the immunoexpression of KAI1, MMP-2, MMP-9 and steroid receptors expression in endometrial cancer.Folia Histochem Cytobiol. 2014;52(3):187-94. doi: 10.5603/FHC.2014.0022.
|
| 188 |
Rearrangement and allelic imbalance on chromosome 5 leads to homozygous deletions in the CDKN2A/2B tumor suppressor gene region in rat endometrial cancer.Cancer Genet Cytogenet. 2008 Jul;184(1):9-21. doi: 10.1016/j.cancergencyto.2008.02.016.
|
| 189 |
CHD4 mutations promote endometrial cancer stemness by activating TGF-beta signaling.Am J Cancer Res. 2018 May 1;8(5):903-914. eCollection 2018.
|
| 190 |
RNA interference targeting CHFR enhances taxol chemosensitivity in endometrial cancer cells.Oncol Rep. 2012 Jul;28(1):248-54. doi: 10.3892/or.2012.1752. Epub 2012 Apr 2.
|
| 191 |
CTCF Expression is Essential for Somatic Cell Viability and Protection Against Cancer.Int J Mol Sci. 2018 Nov 30;19(12):3832. doi: 10.3390/ijms19123832.
|
| 192 |
CTHRC1 promotes M2-like macrophage recruitment and myometrial invasion in endometrial carcinoma by integrin-Akt signaling pathway.Clin Exp Metastasis. 2019 Aug;36(4):351-363. doi: 10.1007/s10585-019-09971-4. Epub 2019 May 22.
|
| 193 |
Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.Int J Gynecol Cancer. 2008 Jan-Feb;18(1):152-8. doi: 10.1111/j.1525-1438.2007.00966.x. Epub 2007 Apr 26.
|
| 194 |
The R156R ERCC2 polymorphism as a risk factor of endometrial cancer.Tumour Biol. 2016 Feb;37(2):2171-6. doi: 10.1007/s13277-015-4040-8. Epub 2015 Sep 9.
|
| 195 |
Mutations and amplification of oncogenes in endometrial cancer.Oncology. 1999;56(1):59-65. doi: 10.1159/000011931.
|
| 196 |
Generation of Mouse for Conditional Expression of Forkhead Box A2.Endocrinology. 2018 Apr 1;159(4):1897-1909. doi: 10.1210/en.2018-00158.
|
| 197 |
Tumor-suppressor role of miR-139-5p in endometrial cancer.Cancer Cell Int. 2018 Apr 2;18:51. doi: 10.1186/s12935-018-0545-8. eCollection 2018.
|
| 198 |
HNRNP G and HTRA2-BETA1 regulate estrogen receptor alpha expression with potential impact on endometrial cancer.BMC Cancer. 2015 Feb 27;15:86. doi: 10.1186/s12885-015-1088-1.
|
| 199 |
Krppel-like factor 9 loss-of-expression in human endometrial carcinoma links altered expression of growth-regulatory genes with aberrant proliferative response to estrogen.Biol Reprod. 2011 Aug;85(2):378-85. doi: 10.1095/biolreprod.110.090654. Epub 2011 May 4.
|
| 200 |
Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.Oncotarget. 2012 Dec;3(12):1546-56. doi: 10.18632/oncotarget.667.
|
| 201 |
Loss of tricellular tight junction protein LSR promotes cell invasion and migration via upregulation of TEAD1/AREG in human endometrial cancer.Sci Rep. 2017 Jan 10;7:37049. doi: 10.1038/srep37049.
|
| 202 |
Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer.Gynecol Oncol. 2004 Sep;94(3):661-70. doi: 10.1016/j.ygyno.2004.05.024.
|
| 203 |
Nucleobindin 2 (NUCB2) in human endometrial carcinoma: a potent prognostic factor associated with cell proliferation and migration.Endocr J. 2016;63(3):287-99. doi: 10.1507/endocrj.EJ15-0490. Epub 2016 Feb 4.
|
| 204 |
Downregulation of PDCD4 induced by progesterone is mediated by the PI3K/AKT signaling pathway in human endometrial cancer cells.Oncol Rep. 2019 Aug;42(2):849-856. doi: 10.3892/or.2019.7202. Epub 2019 Jun 18.
|
| 205 |
Precision Therapy for Aggressive Endometrial Cancer by Reactivation of Protein Phosphatase 2A.Cancer Res. 2019 Aug 15;79(16):4009-4010. doi: 10.1158/0008-5472.CAN-19-1938.
|
| 206 |
Endocrine gland-derived vascular endothelial growth factor is expressed in human peri-implantation endometrium, but not in endometrial carcinoma.Endocrinology. 2006 Jan;147(1):88-95. doi: 10.1210/en.2005-0543. Epub 2005 Oct 6.
|
| 207 |
Potential of RASSF1A promoter methylation as biomarker for endometrial cancer: A systematic review and meta-analysis.Gynecol Oncol. 2017 Sep;146(3):603-608. doi: 10.1016/j.ygyno.2017.06.017. Epub 2017 Jun 29.
|
| 208 |
Role of ribosomal protein mutations in tumor development (Review).Int J Oncol. 2016 Apr;48(4):1313-24. doi: 10.3892/ijo.2016.3387. Epub 2016 Feb 9.
|
| 209 |
Mig-6 Mouse Model of Endometrial Cancer.Adv Exp Med Biol. 2017;943:243-259. doi: 10.1007/978-3-319-43139-0_8.
|
| 210 |
The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia.Gynecol Oncol. 2018 Mar;148(3):485-490. doi: 10.1016/j.ygyno.2017.12.026. Epub 2017 Dec 28.
|
| 211 |
MicroRNA?09 may function as a tumor suppressor in endometrial carcinoma cells by targeting Smad2.Mol Med Rep. 2019 Jan;19(1):622-628. doi: 10.3892/mmr.2018.9642. Epub 2018 Nov 12.
|
| 212 |
Molecular markers of endometrial carcinoma detected in uterine aspirates.Int J Cancer. 2011 Nov 15;129(10):2435-44. doi: 10.1002/ijc.25901. Epub 2011 Apr 8.
|
| 213 |
SOX17 in cellular reprogramming and cancer.Semin Cancer Biol. 2020 Dec;67(Pt 1):65-73. doi: 10.1016/j.semcancer.2019.08.008. Epub 2019 Aug 13.
|
| 214 |
Prostaglandin E2 (PGE2) promotes proliferation and invasion by enhancing SUMO-1 activity via EP4 receptor in endometrial cancer.Tumour Biol. 2016 Sep;37(9):12203-12211. doi: 10.1007/s13277-016-5087-x. Epub 2016 May 26.
|
| 215 |
Significance of TGFBR3 allelic loss in the deregulation of TGF signaling in primary human endometrial carcinomas.Oncol Rep. 2016 Feb;35(2):932-8. doi: 10.3892/or.2015.4400. Epub 2015 Nov 5.
|
| 216 |
Silencing of the icb-1 gene inhibits the induction of differentiation-associated genes by vitamin D3 and all-trans retinoic acid in gynecological cancer cells.Int J Mol Med. 2011 Jul;28(1):121-7. doi: 10.3892/ijmm.2011.663. Epub 2011 Mar 31.
|
| 217 |
Expressions and significances of TTF-1 and PTEN in early endometrial cancer.Eur Rev Med Pharmacol Sci. 2017 Jul;21(3 Suppl):20-26.
|
| 218 |
Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.Gynecol Oncol. 2009 Jan;112(1):229-34. doi: 10.1016/j.ygyno.2008.09.039. Epub 2008 Nov 12.
|
| 219 |
Clinical and Expression Significance of AKT1 by Co-expression Network Analysis in Endometrial Cancer.Front Oncol. 2019 Nov 6;9:1147. doi: 10.3389/fonc.2019.01147. eCollection 2019.
|
| 220 |
Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings.Clin Epigenetics. 2019 Nov 28;11(1):170. doi: 10.1186/s13148-019-0765-3.
|
| 221 |
Leupaxin is expressed in mammary carcinoma and acts as a transcriptional activator of the estrogen receptor .Int J Oncol. 2015 Jul;47(1):106-14. doi: 10.3892/ijo.2015.2988. Epub 2015 May 6.
|
| 222 |
Overexpression of peroxiredoxin-3 and -5 is a potential biomarker for prognosis in endometrial cancer.Oncol Lett. 2018 Apr;15(4):5111-5118. doi: 10.3892/ol.2018.7909. Epub 2018 Jan 31.
|
| 223 |
Changes in Expression Pattern of SEMA3F Depending on Endometrial Cancer Grade - Pilot Study.Curr Pharm Biotechnol. 2019;20(9):727-732. doi: 10.2174/1389201020666190619145655.
|
| 224 |
Sirtuin-7 knockdown inhibits the growth of endometrial cancer cells by inducing apoptosis via the NF-B signaling pathway.Oncol Lett. 2019 Jan;17(1):937-943. doi: 10.3892/ol.2018.9698. Epub 2018 Nov 14.
|
| 225 |
MicroRNA-23a inhibits endometrial cancer cell development by targeting SIX1.Oncol Lett. 2019 Oct;18(4):3792-3802. doi: 10.3892/ol.2019.10694. Epub 2019 Jul 31.
|
| 226 |
Mitochondrial supercomplex assembly promotes breast and endometrial tumorigenesis by metabolic alterations and enhanced hypoxia tolerance.Nat Commun. 2019 Sep 11;10(1):4108. doi: 10.1038/s41467-019-12124-6.
|
| 227 |
Expression of DCC and netrin-1 in normal human endometrium and its implication in endometrial carcinogenesis.Gynecol Oncol. 2004 Nov;95(2):281-9. doi: 10.1016/j.ygyno.2004.07.050.
|
| 228 |
EMP2 is a novel therapeutic target for endometrial cancer stem cells.Oncogene. 2017 Oct 19;36(42):5793-5807. doi: 10.1038/onc.2017.142. Epub 2017 Jun 12.
|
| 229 |
Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ER in Tamoxifen-Associated Endometrial Carcinomas.Cancer Res. 2016 Jul 1;76(13):3773-84. doi: 10.1158/0008-5472.CAN-14-1813. Epub 2016 May 6.
|
| 230 |
New routes to old places: PIK3R1 and PIK3R2 join PIK3CA and PTEN as endometrial cancer genes.Cancer Discov. 2011 Jul;1(2):106-7. doi: 10.1158/2159-8290.CD-11-0116.
|
| 231 |
Rap1GAP inhibits tumor progression in endometrial cancer.Biochem Biophys Res Commun. 2017 Apr 1;485(2):476-483. doi: 10.1016/j.bbrc.2017.02.044. Epub 2017 Feb 11.
|
| 232 |
Mammaglobin B expression in human endometrial cancer.Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1090-6. doi: 10.1111/j.1525-1438.2007.01137.x. Epub 2007 Nov 16.
|
| 233 |
MicroRNA-449a Inhibits Tumor Metastasis through AKT/ERK1/2 Inactivation by Targeting Steroid Receptor Coactivator (SRC) in Endometrial Cancer.J Cancer. 2019 Jan 1;10(2):547-555. doi: 10.7150/jca.27748. eCollection 2019.
|
| 234 |
LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment.J Clin Invest. 2015 Nov 2;125(11):4063-76. doi: 10.1172/JCI82152. Epub 2015 Sep 28.
|
| 235 |
Can ABCF2 protein expression predict the prognosis of uterine cancer?.Br J Cancer. 2008 Nov 18;99(10):1651-5. doi: 10.1038/sj.bjc.6604734.
|
| 236 |
Oncogenic role of ABHD5 in endometrial cancer.Cancer Manag Res. 2019 Mar 14;11:2139-2150. doi: 10.2147/CMAR.S188648. eCollection 2019.
|
| 237 |
Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis.Sci Rep. 2017 Aug 18;7(1):8803. doi: 10.1038/s41598-017-09169-2.
|
| 238 |
MiR-218 suppresses metastasis and invasion of endometrial cancer via negatively regulating ADD2.Eur Rev Med Pharmacol Sci. 2019 Feb;23(4):1408-1417. doi: 10.26355/eurrev_201902_17097.
|
| 239 |
G-protein coupled receptor 64 (GPR64) acts as a tumor suppressor in endometrial cancer.BMC Cancer. 2019 Aug 14;19(1):810. doi: 10.1186/s12885-019-5998-1.
|
| 240 |
Adenylosuccinate lyase enhances aggressiveness of endometrial cancer by increasing killer cell lectin-like receptor C3 expression by fumarate.Lab Invest. 2018 Apr;98(4):449-461. doi: 10.1038/s41374-017-0017-0. Epub 2018 Feb 21.
|
| 241 |
Loss of AF-6/afadin induces cell invasion, suppresses the formation of glandular structures and might be a predictive marker of resistance to chemotherapy in endometrial cancer.BMC Cancer. 2015 Apr 12;15:275. doi: 10.1186/s12885-015-1286-x.
|
| 242 |
AMG 479, a novel IGF-1-R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways.Reprod Sci. 2011 Sep;18(9):832-41. doi: 10.1177/1933719111398501.
|
| 243 |
Anti-Mllerian Hormone Expression in Endometrial Cancer Tissue.Int J Mol Sci. 2019 Mar 15;20(6):1325. doi: 10.3390/ijms20061325.
|
| 244 |
Estrogen receptor alpha activates MAPK signaling pathway to promote the development of endometrial cancer.J Cell Biochem. 2019 Oct;120(10):17593-17601. doi: 10.1002/jcb.29027. Epub 2019 May 29.
|
| 245 |
AQP2 is regulated by estradiol in human endometrium and is associated with spheroid attachment invitro.Mol Med Rep. 2019 Aug;20(2):1306-1312. doi: 10.3892/mmr.2019.10338. Epub 2019 Jun 5.
|
| 246 |
Trocar site hernia development in patients undergoing robotically assisted or standard laparoscopic staging surgery for endometrial cancer.Gynecol Oncol. 2017 Nov;147(2):371-374. doi: 10.1016/j.ygyno.2017.09.005. Epub 2017 Sep 22.
|
| 247 |
Cytochrome P450 1A1 gene polymorphisms and endometrial cancer risk: a meta-analysis.Int J Gynecol Cancer. 2011 Feb;21(2):323-31. doi: 10.1097/IGC.0b013e31820575c0.
|
| 248 |
Expression of renin-angiotensin system (RAS) components in endometrial cancer.Endocr Connect. 2017 Jan;6(1):9-19. doi: 10.1530/EC-16-0082. Epub 2016 Dec 12.
|
| 249 |
Expression of gastrin-releasing peptide receptors in endometrial cancer.J Am Coll Surg. 2003 Jun;196(6):898-904. doi: 10.1016/S1072-7515(03)00290-4.
|
| 250 |
Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma.Int J Cancer. 2017 Apr 1;140(7):1551-1563. doi: 10.1002/ijc.30573. Epub 2017 Feb 2.
|
| 251 |
Colorectal and Endometrial Cancer Risk and Age at Diagnosis in BLMAsh Mutation Carriers.Isr Med Assoc J. 2017 Jun;19(6):365-367.
|
| 252 |
The Role of Sialyl-Tn in Cancer.Int J Mol Sci. 2016 Feb 24;17(3):275. doi: 10.3390/ijms17030275.
|
| 253 |
Expression of calbindin-D28k is inversely correlated with proapototic gene expression in hydrogen peroxide-induced cell death in endometrial cancer cells.Int J Oncol. 2011 Apr;38(4):1059-66. doi: 10.3892/ijo.2011.916. Epub 2011 Jan 21.
|
| 254 |
Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment.Clin Cancer Res. 2017 Nov 1;23(21):6458-6467. doi: 10.1158/1078-0432.CCR-17-0474. Epub 2017 Aug 8.
|
| 255 |
Genetic polymorphism of PRKCDBP is associated with an increased risk of endometrial cancer.Cancer Invest. 2012 Nov;30(9):642-5. doi: 10.3109/07357907.2012.727054. Epub 2012 Sep 28.
|
| 256 |
Expression of human Biot2 and its potential function on carcinogenesis in endometrial cancer.Acta Obstet Gynecol Scand. 2007;86(12):1503-9. doi: 10.1080/00016340701736946.
|
| 257 |
Culture characters, genetic background, estrogen/progesterone receptor expression, and tumorigenic activities of frequently used sixteen endometrial cancer cell lines.Clin Chim Acta. 2019 Feb;489:225-232. doi: 10.1016/j.cca.2018.08.013. Epub 2018 Aug 11.
|
| 258 |
Potential new biomarkers for endometrial cancer.Cancer Cell Int. 2019 Jan 21;19:19. doi: 10.1186/s12935-019-0731-3. eCollection 2019.
|
| 259 |
Integrated Epigenomics Analysis Reveals a DNA Methylation Panel for Endometrial Cancer Detection Using Cervical Scrapings.Clin Cancer Res. 2017 Jan 1;23(1):263-272. doi: 10.1158/1078-0432.CCR-16-0863. Epub 2016 Aug 9.
|
| 260 |
CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity.Gynecol Oncol. 2014 Apr;133(1):83-9. doi: 10.1016/j.ygyno.2013.12.006.
|
| 261 |
Long noncoding RNA CHL1-AS1 promotes cell proliferation and migration by sponging miR-6076 to regulate CHL1 expression in endometrial cancer.J Cell Biochem. 2020 Mar;121(3):2655-2663. doi: 10.1002/jcb.29486. Epub 2019 Nov 17.
|
| 262 |
Cold-inducible RNA-binding protein contributes to human antigen R and cyclin E1 deregulation in breast cancer.Mol Carcinog. 2010 Feb;49(2):130-40. doi: 10.1002/mc.20582.
|
| 263 |
Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).Cancer. 2007 Apr 1;109(7):1312-22. doi: 10.1002/cncr.22536.
|
| 264 |
Downregulation of lipolysis-stimulated lipoprotein receptor promotes cell invasion via claudin-1-mediated matrix metalloproteinases in human endometrial cancer.Oncol Lett. 2017 Dec;14(6):6776-6782. doi: 10.3892/ol.2017.7038. Epub 2017 Sep 22.
|
| 265 |
Quantitative DNA methylation analysis of selected genes in endometrial carcinogenesis.Taiwan J Obstet Gynecol. 2015 Oct;54(5):572-9. doi: 10.1016/j.tjog.2015.08.010.
|
| 266 |
miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.Cancer Res. 2011 Oct 15;71(20):6450-62. doi: 10.1158/0008-5472.CAN-11-0364. Epub 2011 Aug 25.
|
| 267 |
MicroRNA-183 induces epithelial-mesenchymal transition and promotes endometrial cancer cell migration and invasion in by targeting CPEB1.J Cell Biochem. 2018 Nov;119(10):8123-8137. doi: 10.1002/jcb.26763. Epub 2018 Jun 20.
|
| 268 |
HE4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival.Int J Mol Sci. 2013 Nov 18;14(11):22655-77. doi: 10.3390/ijms141122655.
|
| 269 |
Disabled-1 is a large common fragile site gene, inactivated in multiple cancers.Genes Chromosomes Cancer. 2008 Feb;47(2):165-74. doi: 10.1002/gcc.20519.
|
| 270 |
Expression and clinical significance of the transforming growth factor- signalling pathway in endometrial cancer.Histopathology. 2011 Jul;59(1):63-72. doi: 10.1111/j.1365-2559.2011.03892.x.
|
| 271 |
A mononucleotide repeat in PRRT2 is an important, frequent target of mismatch repair deficiency in cancer.Oncotarget. 2017 Jan 24;8(4):6043-6056. doi: 10.18632/oncotarget.13464.
|
| 272 |
Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer.Epigenetics. 2013 Dec;8(12):1373-83. doi: 10.4161/epi.26781. Epub 2013 Oct 22.
|
| 273 |
Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds. Toxicol Appl Pharmacol. 2009 Apr 1;236(1):85-96.
|
| 274 |
Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3.J Clin Endocrinol Metab. 2012 Jul;97(7):E1316-26. doi: 10.1210/jc.2012-1018. Epub 2012 Apr 6.
|
| 275 |
Frequent immune responses to a cancer/testis antigen, CAGE, in patients with microsatellite instability-positive endometrial cancer.Clin Cancer Res. 2005 May 15;11(10):3949-57. doi: 10.1158/1078-0432.CCR-04-1702.
|
| 276 |
Exome-Wide Rare Variant Analysis From the DiscovEHR Study Identifies Novel Candidate Predisposition Genes for Endometrial Cancer.Front Oncol. 2019 Jul 5;9:574. doi: 10.3389/fonc.2019.00574. eCollection 2019.
|
| 277 |
Identification of a potential prognostic lncRNA-miRNA-mRNA signature in endometrial cancer based on the competing endogenous RNA network.J Cell Biochem. 2019 Nov;120(11):18845-18853. doi: 10.1002/jcb.29200. Epub 2019 Jul 24.
|
| 278 |
Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer.Tumour Biol. 2011 Aug;32(4):769-76. doi: 10.1007/s13277-011-0179-0. Epub 2011 May 11.
|
| 279 |
Dusp6 inhibits epithelial-mesenchymal transition in endometrial adenocarcinoma via ERK signaling pathway.Radiol Oncol. 2019 Sep 24;53(3):307-315. doi: 10.2478/raon-2019-0034.
|
| 280 |
Co-regulatory expression quantitative trait loci mapping: method and application to endometrial cancer.BMC Med Genomics. 2011 Jan 12;4:6. doi: 10.1186/1755-8794-4-6.
|
| 281 |
MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7.Oncol Rep. 2015 May;33(5):2354-60. doi: 10.3892/or.2015.3812. Epub 2015 Feb 20.
|
| 282 |
Evaluation of Changes in the Expression Pattern of EDIL3 in Different Grades of Endometrial Cancer.Curr Pharm Biotechnol. 2019;20(6):483-488. doi: 10.2174/1389201020666190408112822.
|
| 283 |
The Prognostic Significance of Eukaryotic Translation Initiation Factors (eIFs) in Endometrial Cancer.Int J Mol Sci. 2019 Dec 6;20(24):6169. doi: 10.3390/ijms20246169.
|
| 284 |
Association of thymidylate synthase gene with endometrial cancer risk in a Chinese population.Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):579-84. doi: 10.1158/1055-9965.EPI-08-0831. Epub 2009 Feb 3.
|
| 285 |
miR-148b Functions as a Tumor Suppressor by Targeting Endoplasmic Reticulum Metallo Protease 1 in Human Endometrial Cancer Cells.Oncol Res. 2018 Dec 27;27(1):81-88. doi: 10.3727/096504018X15202988139874. Epub 2018 Mar 9.
|
| 286 |
Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion.Clin Exp Metastasis. 2015 Jun;32(5):467-78. doi: 10.1007/s10585-015-9720-7. Epub 2015 Apr 30.
|
| 287 |
FAT4-USP51 complex regulates the proliferation and invasion of endometrial cancer via Hippo pathway.Am J Transl Res. 2019 May 15;11(5):2784-2800. eCollection 2019.
|
| 288 |
Flotillin-1 protein is upregulated in human endometrial cancer and localization shifts from epithelial to stromal with increasing tumor grade.Cancer Invest. 2016;34(1):26-31. doi: 10.3109/07357907.2015.1084313. Epub 2015 Dec 18.
|
| 289 |
In silico, in vitro and in vivo analysis identifies a potential role for steroid hormone regulation of FOXD3 in endometriosis-associated genes.Hum Reprod. 2016 Feb;31(2):345-54. doi: 10.1093/humrep/dev307. Epub 2015 Dec 23.
|
| 290 |
YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.Cancer Res. 2017 Apr 1;77(7):1637-1648. doi: 10.1158/0008-5472.CAN-15-3084. Epub 2017 Feb 15.
|
| 291 |
The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer.Int J Cancer. 2011 Jun 1;128(11):2613-24. doi: 10.1002/ijc.25606. Epub 2010 Oct 4.
|
| 292 |
Evaluating Myometrial Invasion in Endometrial Cancer: Comparison of Reduced Field-of-view Diffusion-weighted Imaging and Dynamic Contrast-enhanced MR Imaging.Magn Reson Med Sci. 2018 Jan 10;17(1):28-34. doi: 10.2463/mrms.mp.2016-0128. Epub 2017 May 18.
|
| 293 |
Joint Effect of Genotypic and Phenotypic Features of Reproductive Factors on Endometrial Cancer Risk.Sci Rep. 2015 Oct 26;5:15582. doi: 10.1038/srep15582.
|
| 294 |
Comprehensive Assessment of GPR68 Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody.Int J Mol Sci. 2019 Oct 23;20(21):5261. doi: 10.3390/ijms20215261.
|
| 295 |
The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ER and enhancing enhancer-promoter interactions.J Biol Chem. 2019 Dec 20;294(51):19667-19682. doi: 10.1074/jbc.RA119.010704. Epub 2019 Nov 19.
|
| 296 |
SUMO-1 Promotes Ishikawa Cell Proliferation and Apoptosis in Endometrial Cancer by Increasing Sumoylation of Histone H4.Int J Gynecol Cancer. 2015 Oct;25(8):1364-8. doi: 10.1097/IGC.0000000000000501.
|
| 297 |
Medroxyprogesterone acetate causes the alterations of endoplasmic reticulum related mRNAs and lncRNAs in endometrial cancer cells.BMC Med Genomics. 2019 Nov 12;12(1):163. doi: 10.1186/s12920-019-0601-9.
|
| 298 |
X chromosome-linked long noncoding RNA lnc-XLEC1 regulates c-Myc-dependent cell growth by collaborating with MBP-1 in endometrial cancer.Int J Cancer. 2019 Aug 15;145(4):927-940. doi: 10.1002/ijc.32166. Epub 2019 Feb 23.
|
| 299 |
Identification of key pathways and genes in endometrial cancer using bioinformatics analyses.Oncol Lett. 2019 Jan;17(1):897-906. doi: 10.3892/ol.2018.9667. Epub 2018 Nov 5.
|
| 300 |
Cumulative evidence for relationships between multiple variants of HNF1B and the risk of prostate and endometrial cancers.BMC Med Genet. 2018 Jul 27;19(1):128. doi: 10.1186/s12881-018-0640-7.
|
| 301 |
Overexpression of HOMER2 predicts better outcome in low-grade endometrioid endometrial adenocarcinoma.Pathology. 2018 Aug;50(5):499-503. doi: 10.1016/j.pathol.2018.03.004. Epub 2018 Jun 8.
|
| 302 |
miR-10b Inhibits Apoptosis and Promotes Proliferation and Invasion of Endometrial Cancer Cells via Targeting HOXB3.Cancer Biother Radiopharm. 2016 Aug;31(6):225-31. doi: 10.1089/cbr.2016.1998.
|
| 303 |
HOXB9 promotes endometrial cancer progression by targeting E2F3.Cell Death Dis. 2018 May 1;9(5):509. doi: 10.1038/s41419-018-0556-3.
|
| 304 |
A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk.Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12263-8. doi: 10.1073/pnas.192172299. Epub 2002 Sep 6.
|
| 305 |
Methylation status of KLF4 and HS3ST2 genes as predictors of endometrial cancer and hyperplastic endometrial lesions.Int J Mol Med. 2018 Dec;42(6):3318-3328. doi: 10.3892/ijmm.2018.3872. Epub 2018 Sep 12.
|
| 306 |
Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer.Gynecol Oncol. 2005 Aug;98(2):193-202. doi: 10.1016/j.ygyno.2005.02.031.
|
| 307 |
RNA-seq Reveals the Overexpression of IGSF9 in Endometrial Cancer.J Oncol. 2018 Feb 14;2018:2439527. doi: 10.1155/2018/2439527. eCollection 2018.
|
| 308 |
Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women.Int J Cancer. 2009 Mar 15;124(6):1358-65. doi: 10.1002/ijc.24071.
|
| 309 |
Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers.Cancer Med. 2020 Feb;9(3):1092-1103. doi: 10.1002/cam4.2729. Epub 2019 Dec 6.
|
| 310 |
TRIB3 suppresses proliferation and invasion and promotes apoptosis of endometrial cancer cells by regulating the AKT signaling pathway.Onco Targets Ther. 2019 Mar 27;12:2235-2245. doi: 10.2147/OTT.S189001. eCollection 2019.
|
| 311 |
Macrophage ER promoted invasion of endometrial cancer cell by mTOR/KIF5B-mediated epithelial to mesenchymal transition.Immunol Cell Biol. 2019 Jul;97(6):563-576. doi: 10.1111/imcb.12245. Epub 2019 Mar 14.
|
| 312 |
Dysregulation of Krppel-like factor 12 in the development of endometrial cancer.Gynecol Oncol. 2019 Jan;152(1):177-184. doi: 10.1016/j.ygyno.2018.10.028. Epub 2018 Oct 25.
|
| 313 |
Germline PTEN, SDHB-D, and KLLN alterations in endometrial cancer patients with Cowden and Cowden-like syndromes: an international, multicenter, prospective study.Cancer. 2015 Mar 1;121(5):688-96. doi: 10.1002/cncr.29106. Epub 2014 Nov 5.
|
| 314 |
LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.Int J Cancer. 2016 Dec 1;139(11):2529-39. doi: 10.1002/ijc.30371. Epub 2016 Aug 16.
|
| 315 |
miR?15 promotes epithelial to mesenchymal transition and proliferation by regulating LEFTY2 in endometrial cancer.Int J Mol Med. 2018 Sep;42(3):1229-1236. doi: 10.3892/ijmm.2018.3703. Epub 2018 May 22.
|
| 316 |
Galectin-7 is elevated in endometrioid (type I) endometrial cancer and promotes cell migration.Oncol Lett. 2018 Oct;16(4):4721-4728. doi: 10.3892/ol.2018.9193. Epub 2018 Jul 23.
|
| 317 |
Loss of Hugl-1 expression associates with lymph node metastasis in endometrial cancer.Oncol Res. 2007;16(9):431-5. doi: 10.3727/000000007783980855.
|
| 318 |
LRG1 is an independent prognostic factor for endometrial carcinoma.Tumour Biol. 2014 Jul;35(7):7125-33. doi: 10.1007/s13277-014-1953-6. Epub 2014 Apr 24.
|
| 319 |
Induction of the LRP16 gene by estrogen promotes the invasive growth of Ishikawa human endometrial cancer cells through the downregulation of E-cadherin.Cell Res. 2007 Oct;17(10):869-80. doi: 10.1038/cr.2007.79.
|
| 320 |
The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.J Gynecol Oncol. 2018 Jan;29(1):e17. doi: 10.3802/jgo.2018.29.e17.
|
| 321 |
CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer.J Clin Pathol. 2014 Dec;67(12):1067-71. doi: 10.1136/jclinpath-2014-202616. Epub 2014 Oct 3.
|
| 322 |
SOX17 is a tumor suppressor in endometrial cancer.Oncotarget. 2016 Nov 15;7(46):76036-76046. doi: 10.18632/oncotarget.12582.
|
| 323 |
Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.Oncology. 2010;79(3-4):238-46. doi: 10.1159/000322644. Epub 2011 Mar 3.
|
| 324 |
Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer: A Randomized Clinical Trial.JAMA. 2017 Mar 28;317(12):1224-1233. doi: 10.1001/jama.2017.2068.
|
| 325 |
miR-27b-3p/MARCH7 regulates invasion and metastasis of endometrial cancer cells through Snail-mediated pathway.Acta Biochim Biophys Sin (Shanghai). 2019 May 23;51(5):492-500. doi: 10.1093/abbs/gmz030.
|
| 326 |
Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancer.Am J Epidemiol. 2013 Jun 15;177(12):1317-25. doi: 10.1093/aje/kws394. Epub 2013 May 31.
|
| 327 |
MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional Characterization.J Natl Cancer Inst. 2018 May 1;110(5):517-526. doi: 10.1093/jnci/djx238.
|
| 328 |
Loss of MDC1 in Endometrial Carcinoma Is Associated With Loss of MRN Complex and MMR Deficiency.Anticancer Res. 2019 Dec;39(12):6547-6553. doi: 10.21873/anticanres.13870.
|
| 329 |
MDH2 Stimulated by Estrogen-GPR30 Pathway Down-Regulated PTEN Expression Promoting the Proliferation and Invasion of Cells in Endometrial Cancer.Transl Oncol. 2017 Apr;10(2):203-210. doi: 10.1016/j.tranon.2017.01.009. Epub 2017 Feb 9.
|
| 330 |
m(6)A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer.Nat Cell Biol. 2018 Sep;20(9):1074-1083. doi: 10.1038/s41556-018-0174-4. Epub 2018 Aug 27.
|
| 331 |
Aquaporin-1 plays a crucial role in estrogen-induced tubulogenesis of vascular endothelial cells.J Clin Endocrinol Metab. 2013 Apr;98(4):E672-82. doi: 10.1210/jc.2012-4081. Epub 2013 Feb 28.
|
| 332 |
MLH3 mutation in endometrial cancer.Cancer Res. 2006 Aug 1;66(15):7502-8. doi: 10.1158/0008-5472.CAN-06-0248.
|
| 333 |
The MRPS18-2 protein levels correlate with prostate tumor progression and it induces CXCR4-dependent migration of cancer cells.Sci Rep. 2018 Feb 2;8(1):2268. doi: 10.1038/s41598-018-20765-8.
|
| 334 |
A monoclonal antibody (MSN-1) against a newly established uterine endometrial cancer cell line (SNG-II) and its application to immunohistochemistry and flow cytometry.Am J Obstet Gynecol. 1989 Oct;161(4):1079-86. doi: 10.1016/0002-9378(89)90787-4.
|
| 335 |
Epigenetic alteration of the metallothionein 1E gene in human endometrial carcinomas.Tumour Biol. 2009;30(2):93-9. doi: 10.1159/000218032. Epub 2009 May 6.
|
| 336 |
Estrogen receptor transcript variants associate with oncogene expression in endometrial cancer.Int J Mol Med. 2012 Jun;29(6):1127-36. doi: 10.3892/ijmm.2012.929. Epub 2012 Feb 28.
|
| 337 |
DNA methylation promotes paired box 2 expression via myeloid zinc finger 1 in endometrial cancer.Oncotarget. 2016 Dec 20;7(51):84785-84797. doi: 10.18632/oncotarget.12626.
|
| 338 |
Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease.Proc Natl Acad Sci U S A. 2009 May 26;106(21):8677-82. doi: 10.1073/pnas.0903632106. Epub 2009 May 13.
|
| 339 |
Steroid Receptor Coactivator-2 Controls the Pentose Phosphate Pathway through RPIA in Human Endometrial Cancer Cells.Sci Rep. 2018 Sep 3;8(1):13134. doi: 10.1038/s41598-018-31372-y.
|
| 340 |
Neural precursor cell-expressed developmentally down-regulated 4-like: a new biomarker in the pathophysiology of endometrial cancer.J Int Med Res. 2018 Sep;46(9):3709-3716. doi: 10.1177/0300060518777944. Epub 2018 Jul 12.
|
| 341 |
Prognostic role of NF-YA splicing isoforms and Lamin A status in low grade endometrial cancer.Oncotarget. 2017 Jan 31;8(5):7935-7945. doi: 10.18632/oncotarget.13854.
|
| 342 |
Inflammasome as a Key Pathogenic Mechanism in Endometriosis.Curr Drug Targets. 2017;18(9):997-1002. doi: 10.2174/1389450117666160709013850.
|
| 343 |
MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.Cell Cycle. 2018;17(10):1268-1278. doi: 10.1080/15384101.2018.1475829. Epub 2018 Jul 23.
|
| 344 |
Long noncoding RNA NR2F1-AS1 enhances the malignant properties of osteosarcoma by increasing forkhead box A1 expression via sponging of microRNA-483-3p.Aging (Albany NY). 2019 Dec 4;11(23):11609-11623. doi: 10.18632/aging.102563. Epub 2019 Dec 4.
|
| 345 |
New target genes in endometrial tumors show a role for the estrogen-receptor pathway in microsatellite-unstable cancers.Hum Mutat. 2014 Dec;35(12):1514-23. doi: 10.1002/humu.22700.
|
| 346 |
miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation.Oncotarget. 2018 May 1;9(33):23253-23263. doi: 10.18632/oncotarget.25298. eCollection 2018 May 1.
|
| 347 |
Select human cancer mutants of NRMT1 alter its catalytic activity and decrease N-terminal trimethylation.Protein Sci. 2017 Aug;26(8):1639-1652. doi: 10.1002/pro.3202. Epub 2017 Jun 11.
|
| 348 |
OTU Domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1) deubiquitinates estrogen receptor (ER) alpha and affects ERalpha transcriptional activity.J Biol Chem. 2009 Jun 12;284(24):16135-16145. doi: 10.1074/jbc.M109.007484. Epub 2009 Apr 21.
|
| 349 |
The Roles of Glycodelin in Cancer Development and Progression.Front Immunol. 2017 Nov 29;8:1685. doi: 10.3389/fimmu.2017.01685. eCollection 2017.
|
| 350 |
Membrane progesterone receptors and have potential as prognostic biomarkers of endometrial cancer.J Steroid Biochem Mol Biol. 2018 Apr;178:303-311. doi: 10.1016/j.jsbmb.2018.01.011. Epub 2018 Jan 17.
|
| 351 |
PAX2 in endometrial carcinogenesis and in differential diagnosis of endometrial hyperplasia: A systematic review and meta-analysis of diagnostic accuracy.Acta Obstet Gynecol Scand. 2019 Mar;98(3):287-299. doi: 10.1111/aogs.13512. Epub 2019 Jan 8.
|
| 352 |
Endoplasmic reticulum stress-mediated membrane expression of CRT/ERp57 induces immunogenic apoptosis in drug-resistant endometrial cancer cells.Oncotarget. 2017 May 8;8(35):58754-58764. doi: 10.18632/oncotarget.17678. eCollection 2017 Aug 29.
|
| 353 |
PELP1/MNAR suppression inhibits proliferation and metastasis of endometrial carcinoma cells.Oncol Rep. 2012 Dec;28(6):2035-42. doi: 10.3892/or.2012.2038. Epub 2012 Sep 17.
|
| 354 |
A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer.Clin Cancer Res. 2018 Jul 15;24(14):3253-3262. doi: 10.1158/1078-0432.CCR-17-3421. Epub 2018 Apr 10.
|
| 355 |
Piwil1 causes epigenetic alteration of PTEN gene via upregulation of DNA methyltransferase in type I endometrial cancer.Biochem Biophys Res Commun. 2015 Aug 7;463(4):876-80. doi: 10.1016/j.bbrc.2015.06.028. Epub 2015 Jun 6.
|
| 356 |
Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway.Hum Mol Genet. 2006 Jan 15;15(2):201-11. doi: 10.1093/hmg/ddi430. Epub 2005 Dec 23.
|
| 357 |
Progesterone and 1,25-dihydroxyvitamin D? inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3F. Mol Cancer Res. 2011 Nov;9(11):1479-92. doi: 10.1158/1541-7786.MCR-11-0213. Epub 2011 Sep 20.
|
| 358 |
Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome.Int J Clin Oncol. 2019 Sep;24(9):999-1011. doi: 10.1007/s10147-019-01494-y. Epub 2019 Jul 4.
|
| 359 |
The influence of hormone therapy with drospirenone-estradiol on endometrioid type endometrial cancer patients.J Gynecol Oncol. 2018 Sep;29(5):e72. doi: 10.3802/jgo.2018.29.e72. Epub 2018 May 4.
|
| 360 |
Genetics of endometrial cancer.Fam Cancer. 2014 Sep;13(3):499-505. doi: 10.1007/s10689-014-9722-7.
|
| 361 |
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.Gynecol Oncol. 2020 Jan;156(1):194-202. doi: 10.1016/j.ygyno.2019.10.028. Epub 2019 Nov 19.
|
| 362 |
Expression of hPOT1 in HeLa cells and the probability of gene variation of hpot1 Exon14 in endometrial cancer are much higher than in other cancers.Asian Pac J Cancer Prev. 2012;13(11):5659-63. doi: 10.7314/apjcp.2012.13.11.5659.
|
| 363 |
Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer.J Surg Oncol. 2011 Dec;104(7):755-9. doi: 10.1002/jso.22035. Epub 2011 Jul 14.
|
| 364 |
Expression of the retinoblastoma-related gene Rb2/p130 correlates with clinical outcome in endometrial cancer.J Clin Oncol. 1998 Mar;16(3):1085-93. doi: 10.1200/JCO.1998.16.3.1085.
|
| 365 |
Inhibition of PSMD4 blocks the tumorigenesis of hepatocellular carcinoma.Gene. 2019 Jun 20;702:66-74. doi: 10.1016/j.gene.2019.03.063. Epub 2019 Mar 28.
|
| 366 |
Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REG.Cancer Lett. 2015 May 1;360(2):269-79. doi: 10.1016/j.canlet.2015.02.028. Epub 2015 Feb 16.
|
| 367 |
Downregulation of PTPN18 can inhibit proliferation and metastasis and promote apoptosis of endometrial cancer.Clin Exp Pharmacol Physiol. 2019 Aug;46(8):734-742. doi: 10.1111/1440-1681.13098. Epub 2019 May 30.
|
| 368 |
Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses.Cancer Med. 2018 May;7(5):1978-1987. doi: 10.1002/cam4.1445. Epub 2018 Apr 2.
|
| 369 |
Patterns of Failures and Clinical Outcome of Patients with Early-Stage, High-Risk, Node-Negative Endometrial Cancer Treated with Surgery Followed by Adjuvant Platinum-Based Chemotherapy and Vaginal Brachytherapy.Oncology. 2019;96(5):235-241. doi: 10.1159/000492430. Epub 2019 Mar 22.
|
| 370 |
Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status.Br J Cancer. 2001 Aug 17;85(4):546-51. doi: 10.1054/bjoc.2001.1923.
|
| 371 |
Elevated expression of RIT1 correlates with poor prognosis in endometrial cancer.Int J Clin Exp Pathol. 2015 Sep 1;8(9):10315-24. eCollection 2015.
|
| 372 |
Meta-dimensional data integration identifies critical pathways for susceptibility, tumorigenesis and progression of endometrial cancer.Oncotarget. 2016 Aug 23;7(34):55249-55263. doi: 10.18632/oncotarget.10509.
|
| 373 |
Pir2/Rnf144b is a potential endometrial cancer biomarker that promotes cell proliferation. Cell Death Dis. 2018 May 1;9(5):504. doi: 10.1038/s41419-018-0521-1.
|
| 374 |
Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1.JAMA Oncol. 2015 Dec;1(9):1319-23. doi: 10.1001/jamaoncol.2015.2151.
|
| 375 |
Frequent mutations in the RPL22 gene and its clinical and functional implications.Gynecol Oncol. 2013 Mar;128(3):470-4. doi: 10.1016/j.ygyno.2012.10.026. Epub 2012 Nov 2.
|
| 376 |
Expression of Semaphorin 3B (SEMA3B) in Various Grades of Endometrial Cancer.Med Sci Monit. 2019 Jun 20;25:4569-4574. doi: 10.12659/MSM.916762.
|
| 377 |
Assessment of the Usefulness of the SEMA5A Concentration Profile Changes as a Molecular Marker in Endometrial Cancer.Curr Pharm Biotechnol. 2020;21(1):45-51. doi: 10.2174/1389201020666190911113611.
|
| 378 |
Interactions between microRNA-200 family and Sestrin proteins in endometrial cancer cell lines and their significance to anoikis.Mol Cell Biochem. 2019 Sep;459(1-2):21-34. doi: 10.1007/s11010-019-03547-2. Epub 2019 May 9.
|
| 379 |
Association of body mass index with ER, PR and 14-3-3 expression in tumor and stroma of type I and type II endometrial carcinoma.Oncotarget. 2017 Jun 27;8(26):42548-42559. doi: 10.18632/oncotarget.17209.
|
| 380 |
CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility.Cancer. 2008 May 1;112(9):1964-73. doi: 10.1002/cncr.23392.
|
| 381 |
Curcumin exhibits anti-tumor effect and attenuates cellular migration via Slit-2 mediated down-regulation of SDF-1 and CXCR4 in endometrial adenocarcinoma cells.J Nutr Biochem. 2017 Jun;44:60-70. doi: 10.1016/j.jnutbio.2016.12.021. Epub 2017 Mar 16.
|
| 382 |
Para-aortic Lymph Node Invasion in High-risk Endometrial Cancer: Performance of (18)FDG PET-CT.Anticancer Res. 2019 Feb;39(2):619-625. doi: 10.21873/anticanres.13155.
|
| 383 |
SOX11 hypermethylation as a tumor biomarker in endometrial cancer.Biochimie. 2019 Jul;162:8-14. doi: 10.1016/j.biochi.2019.03.019. Epub 2019 Mar 29.
|
| 384 |
Overexpression of microRNA-194 suppresses the epithelial-mesenchymal transition in targeting stem cell transcription factor Sox3 in endometrial carcinoma stem cells.Tumour Biol. 2017 Jun;39(6):1010428317706217. doi: 10.1177/1010428317706217.
|
| 385 |
UBE2S mediates tumor progression via SOX6/-Catenin signaling in endometrial cancer.Int J Biochem Cell Biol. 2019 Apr;109:17-22. doi: 10.1016/j.biocel.2019.01.014. Epub 2019 Jan 25.
|
| 386 |
SPOCK2 Affects the Biological Behavior of Endometrial Cancer Cells by Regulation of MT1-MMP and MMP2.Reprod Sci. 2019 Mar 4:1933719119834341. doi: 10.1177/1933719119834341. Online ahead of print.
|
| 387 |
F-Spondin Is the Signal by Which 2-Methoxyestradiol Induces Apoptosis in the Endometrial Cancer Cell Line Ishikawa.Int J Mol Sci. 2019 Aug 7;20(16):3850. doi: 10.3390/ijms20163850.
|
| 388 |
Uterine function in the mouse requires speckle-type poz protein.Biol Reprod. 2018 Jun 1;98(6):856-869. doi: 10.1093/biolre/ioy060.
|
| 389 |
Association between the expression of secreted phosphoprotein - related genes and prognosis of human cancer.BMC Cancer. 2019 Dec 18;19(1):1230. doi: 10.1186/s12885-019-6441-3.
|
| 390 |
Associations between a single nucleotide polymorphism of stress-induced phosphoprotein 1 and endometriosis/adenomyosis.Taiwan J Obstet Gynecol. 2018 Apr;57(2):270-275. doi: 10.1016/j.tjog.2018.03.001.
|
| 391 |
Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a.Int J Mol Sci. 2017 Jun 22;18(7):1337. doi: 10.3390/ijms18071337.
|
| 392 |
Downregulation of endometrial mesenchymal marker SUSD2 causes cell senescence and cell death in endometrial carcinoma cells.PLoS One. 2017 Aug 25;12(8):e0183681. doi: 10.1371/journal.pone.0183681. eCollection 2017.
|
| 393 |
TESTIN was commonly hypermethylated and involved in the epithelial-mesenchymal transition of endometrial cancer.APMIS. 2015 May;123(5):394-400. doi: 10.1111/apm.12361. Epub 2015 Feb 27.
|
| 394 |
Differential expression of ten-eleven translocation genes in endometrial cancers.Tumour Biol. 2017 Mar;39(3):1010428317695017. doi: 10.1177/1010428317695017.
|
| 395 |
Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.Gynecol Oncol. 2018 Jun;149(3):592-597. doi: 10.1016/j.ygyno.2018.03.057. Epub 2018 Mar 28.
|
| 396 |
Nucleophosmin/B23 is a negative regulator of estrogen receptor expression via AP2 in endometrial cancer cells.Oncotarget. 2016 Sep 13;7(37):60038-60052. doi: 10.18632/oncotarget.11048.
|
| 397 |
Thrombospondin-1 and -2 messenger RNA expression in normal and neoplastic endometrial tissues: correlation with angiogenesis and prognosis.Int J Oncol. 2001 Aug;19(2):305-10. doi: 10.3892/ijo.19.2.305.
|
| 398 |
Imbalanced expression of TAN-1 and human Notch4 in endometrial cancers.Int J Oncol. 2000 Dec;17(6):1131-9. doi: 10.3892/ijo.17.6.1131.
|
| 399 |
Association of TNFAIP8 gene polymorphisms with endometrial cancer in northern Chinese women.Cancer Cell Int. 2019 Apr 23;19:105. doi: 10.1186/s12935-019-0827-9. eCollection 2019.
|
| 400 |
Identification of DNA methylation associated gene signatures in endometrial cancer via integrated analysis of DNA methylation and gene expression systematically.J Gynecol Oncol. 2017 Nov;28(6):e83. doi: 10.3802/jgo.2017.28.e83.
|
| 401 |
Expression of TRA2B in endometrial carcinoma and its regulatory roles in endometrial carcinoma cells.Oncol Lett. 2019 Sep;18(3):2455-2463. doi: 10.3892/ol.2019.10553. Epub 2019 Jul 3.
|
| 402 |
RETRACTED: TRAF4 promotes endometrial cancer cell growth and migration by activation of PI3K/AKT/Oct4 signaling.Exp Mol Pathol. 2019 Jun;108:9-16. doi: 10.1016/j.yexmp.2019.03.003. Epub 2019 Mar 7.
|
| 403 |
Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.Cell Biochem Biophys. 2015 Jun;72(2):515-25. doi: 10.1007/s12013-014-0497-0.
|
| 404 |
Identification of TRIM22 as a progesterone-responsive gene in Ishikawa endometrial cancer cells.J Steroid Biochem Mol Biol. 2015 Nov;154:217-25. doi: 10.1016/j.jsbmb.2015.08.024. Epub 2015 Aug 24.
|
| 405 |
High TRIM44 expression in endometrial carcinoma is associated with a poorer patient outcome.Pathol Res Pract. 2018 May;214(5):727-731. doi: 10.1016/j.prp.2018.03.007. Epub 2018 Mar 6.
|
| 406 |
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.Sci Rep. 2015 Dec 1;5:17369. doi: 10.1038/srep17369.
|
| 407 |
Expression of tumor suppressor genes related to the cell cycle in endometrial cancer patients.Adv Med Sci. 2016 Sep;61(2):317-324. doi: 10.1016/j.advms.2016.04.001. Epub 2016 Apr 13.
|
| 408 |
Sperm protein 17 is highly expressed in endometrial and cervical cancers.BMC Cancer. 2010 Aug 16;10:429. doi: 10.1186/1471-2407-10-429.
|
| 409 |
LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT?.Gynecol Oncol. 2020 Jan;156(1):243-250. doi: 10.1016/j.ygyno.2019.09.016. Epub 2019 Nov 5.
|
| 410 |
Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in Endometrial Cancer is Associated With Adverse Histologic Parameters and Tumor Progression.Appl Immunohistochem Mol Morphol. 2020 Jul;28(6):453-459. doi: 10.1097/PAI.0000000000000763.
|
| 411 |
Hypoxia is involved in the reduction of HtrA3 in patients with endometrial hyperplasia and cancer.Biochem Biophys Res Commun. 2018 Sep 18;503(4):2918-2923. doi: 10.1016/j.bbrc.2018.08.070. Epub 2018 Aug 20.
|
| 412 |
Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet. 1997 Nov;17(3):271-2. doi: 10.1038/ng1197-271.
|
| 413 |
High expression of MUC20 drives tumorigenesis and predicts poor survival in endometrial cancer.J Cell Biochem. 2019 Jul;120(7):11859-11866. doi: 10.1002/jcb.28466. Epub 2019 Feb 19.
|
| 414 |
Abnormal Expression of PICT-1 and Its Codon 389 Polymorphism Is a Risk Factor for Human Endometrial Cancer.Oncology. 2018;95(1):43-51. doi: 10.1159/000487189. Epub 2018 Apr 4.
|
| 415 |
PGK1 facilities cisplatin chemoresistance by triggering HSP90/ERK pathway mediated DNA repair and methylation in endometrial endometrioid adenocarcinoma.Mol Med. 2019 Mar 29;25(1):11. doi: 10.1186/s10020-019-0079-0.
|
| 416 |
Alternative splicing of VEGFA is regulated by RBM10 in endometrial cancer.Kaohsiung J Med Sci. 2020 Jan;36(1):13-19. doi: 10.1002/kjm2.12127. Epub 2019 Oct 6.
|
| 417 |
Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: diagnostic and possible therapeutic implications.Mod Pathol. 2006 Jun;19(6):797-803. doi: 10.1038/modpathol.3800586.
|
| 418 |
Investigation of resistin 420 and 62 gene polymorphism in patients with endometrial cancer.Taiwan J Obstet Gynecol. 2019 Jan;58(1):164-167. doi: 10.1016/j.tjog.2018.11.030.
|
|
|
|
|
|
|
